Use of hypo-osmotic saline solutions and medicine based on said solutions
US6855325B1 · kind B1 · utility
10Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 2000 |
| Grant date | Feb 15, 2005 |
| Priority date | — |
| Expiry date | Aug 18, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61Q19/005
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Treatment for preventing and limiting the release of the chemical mediators which are responsible of the starting of cutaneous inflammatory phenomena comprising administration to a patient of hypoosmotic saline solutions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.